| |
Scope
Photodiagnosis and Photodynamic
Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and
Photodynamic Therapy in all medical specialities. The journal publishes original articles, review articles, case presentations, "how-to-do-it"
articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject
to a strict peer review process.
Types of manuscript
Original Articles
should report original clinical studies or research not previously published or being considered for publication elsewhere. Work in Progress
may also be submitted. See below for the standard layout. Submission of a manuscript to this journal gives the publisher the right to
publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression.
Review articles, including
institutional reviews of recent developments are welcome, and will undergo peer review. Reviews should have an abstract of up to 250
words.
Editorials
Although most Editorials in the journal are commissioned, authors may contact the Editor-in-Chief to
request submission of their own Editorial.
Letters to the Editor. Readers are encouraged to write about any topic that relates
to photodiagnosis or photodynamic therapy, clinical, scientific, educational, social or economic. Letters should be no longer than 500
words and may include discussions on material previously printed in the Journal.
Case Presentations will be considered if formatted
as a research letter with 2 figures maximum. Maximum length is up to 1000 words with up to 6 references and 2 tables or figures. There
should be no Abstract and no headings.
How-to-do-it articles should be a description of a useful technique and contain descriptive,
illustrative material. These articles are limited to a total of 1500 words including title page, abstract, text, references and figure
legends. For each illustration subtract 100 words and for each table subtract 300 words from the word limit. References are limited to
eight.
Short Communications should not exceed 1000 words and should consist of a background section (not to exceed 100 words),
aims (not to exceed 50 words), methods (not to exceed 250 words), results (not to exceed 250 words) and conclusion (not to exceed 250
words). The editorial team reserves the right to decide which tables/figures submitted are necessary. No abstract is necessary.
Relevant
images with short description are limited to 350 words including title and text and to two, possibly three figures. The entire
contribution must fit on one printed page of the journal.
Posters
Posters should be submitted as size A4 and should
comprise the following sections: (1) Background/Objectives, (2) Material and Methods, (3) Results and (4) Conclusions/Message To Take
Home. A maximum of 4 authors per poster is allowed. A maximum of 5 figures and tables are permitted and references should be limited
to 4. An abstract of maximum 300 words should be provided (to be printed on the page facing the Poster) which should be structured and
may contain additional information.
Posters should be submitted together with the written agreement of ALL authors. Authors retain
the copyright of the original article. The Poster will not be considered as a duplicate publication if the authors wish to publish the
full article of the subject in this journal or any other. Posters are reviewed by one reviewer plus the Editor or one of the journal's
Associate Editors.
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see  http://www.elsevier.com/publishingethics
and http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other
relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence,
or be perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously
(except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any
other language, without the written consent of the copyright-holder.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this
and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination
of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists
of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale
or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions).
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit
the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to: http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such
involvement then this should be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit http://www.elsevier.com/languageediting or our customer support site at http://epsupport.elsevier.com
for more information.
Submission
Submission to this journal proceeds totally
online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files
to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are
converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All
correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for
a paper trail.
Referees
Please submit, with the manuscript, the names,
addresses and e-mail addresses of 3 potential referees. Note that the editor retains the sole right to decide whether or not the suggested
reviewers are used.
Revised version of the manuscrip
On the basis
of the comments of the referees and editors, Authors may be asked to revise their manuscript. In order to facilitate the evaluation of
the revisions by the referees and editors, upon revision, Authors are asked: oto indicate all changes to the original manuscript by means
of 'track changes' oto add a letter for the referees, explaining how they dealt with all of the recommendations and questions from the
referees. Authors should submit their revised version no later than 9 months after they were informed about the decision that the manuscript
needs revision. If no revised manuscript is received 9 months after the decision, the manuscript will be considered as rejected.
Style
Please use no abbreviations.
Headlines and Subheadlines should be liberally employed in the Methods, Results, and Discussion sections. Use short paragraphs whenever
possible. Clarity of expression, good syntax and the avoidance of medical jargon will be appreciated by the editors, reviewers and readers.
Layout of manuscript
Divide the manuscript into the following sections: Title page, Structured Abstract,
Key words (3-6), Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References. The editors will consider the
use of other sections if more suitable for certain manuscripts.
Essential title page
information
•
Title.
Concise and informative. Titles are often used in information-retrieval systems.
Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name may be
ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front
of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail
address of each author.
•
Corresponding author.
Clearly indicate who will handle correspondence at all stages
of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided
in addition to the e-mail address and the complete postal address.
•
Present/permanent address.
If an author
has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address")
may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main,
affiliation address. Superscript Arabic numerals are used for such footnotes.
The Structured Abstract, of no more than 250 words, should be written with particular care since this will be the only part
of the article studied by some readers. The preferred subheadings are: Background, Methods, Results and Conclusions.
The Introduction
should be brief and set out the purposes for which the study has been performed along with relevant previous studies only where essential.
The Materials and Methods should be sufficiently detailed so that readers and reviewers can understand precisely what has
been done without studying the references directly. The description may be abbreviated when well accepted techniques are used.
The Results should be presented precisely. Keep discussion of their importance to a minimum in this section of the manuscript.
The Discussion should directly relate to the study being reported. Do not include a general review of the topic.
References
should be numbered consecutively (with brackets) as they appear in the text. Type the reference list with double spacing on a separate
sheet. References should accord with the system used in Uniform requirements for manuscripts submitted to biomedical journals (N Engl
J Med 1991; 324: 424-428). Examples:
[1] De Soyza N, Thenabadu PN, Murphy ML, Kane JJ, Doherty JE. Ventricular arrhythmia before
and after aortocoronary bypass surgery. Int J Cardiol 1981; 1:123-130.
[2] Akutsu T. Artificial heart: total replacement and partial
support. Amsterdam: Elsevier/North-Holland, 1975.
[3] Goldman RH. Digitalis toxicity. In: Bristow MR, editors. Drug-induced heart
disease. Amsterdam: Elsevier/North-Holland, 1980:217-40. Please note that all authors should be listed when six or less; when seven or
more, list only the first three and add et al. Do not include references to personal communications, unpublished data or manuscripts
either "in preparation" or "submitted for publication". If essential, such material may be incorporated into the appropriate place in
the text. Recheck references in the text against reference list after your manuscript has been revised.
Tables should
be typed with double spacing and each should be on a separate sheet. They should be numbered consecutively with Arabic numerals, and
contain only horizontal lines. Provide a short descriptive heading above each table with footnotes and/or explanations underneath.
Figures should ideally be submitted in high-resolution TIF format, or alternatively in GIF, JPEG/JPG, or EPS format. The figures
should be placed in separate files, named purely with the figure numbers (e.g. "Figure1.tif".) The cost of colour figures will be paid
by the author.
Legends for Figures should be typed with double-spacing on a separate sheet.
Gene Accession Numbers
For each and every gene accession number cited in an article, authors should type the accession number in bold, underlined text. Letters
in the accession number should always be capitalised. Example: (GenBank accession nos. AI631510 , AI631511 , AI632198, and BF223228 ),
a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048 ), and a T-cell lymphoma (GenBank accession no. AA361117
).
Supplementary data
The journal accepts electronic supplementary material to support and enhance your scientific research.
Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution
images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version
of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com
Electronic artwork
General points
• Make sure you use uniform lettering and sizing
of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following
fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
•
Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide
on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged
to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application
used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save
the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line
drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please
do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that
are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color
artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct
resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge,
that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations
are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs
from Elsevier after receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For
further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Please
note: Because of technical complications which can arise by converting color figures to "gray scale" (for the printed version should
you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior
to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure
that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full
postal address
• Telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure
captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked"
and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference
list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources
(including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge)
and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the
Web is required, black and white versions of the figures are also supplied for printing purposes
For any further information please
visit our customer support site at http://epsupport.elsevier.com.
Process of submission
Online submission
Photodiagnosis and Photodynamic Therapy uses
an online submission and review system. Authors can upload their article via the Elsevier Editorial System at http://ees.elsevier.com/pdpdt.
By accessing the website Authors will be guided stepwise through the uploading of the various files. Editable file formats are necessary.
We accept most wordprocessing formats, but Word, WordPerfect or LaTeX is preferred. Figure files (TIFF, EPS, JPEG) should be uploaded
separately. Always keep a backup copy of the electronic file for reference and safety. Save your files using the default extension of
the program used. The system generates an Adobe Acrobat PDF version of the article which is used for the reviewing process. Authors,
Reviewers and Editors send and receive all correspondence by e-mail and no paper correspondence is necessary. For assistance contact
Author Support at authorsupport@elsevier.com
Use of the Digital Object Identifier
The Digital Object Identifier (DOI)
may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to
a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The
correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how
to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and
return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then
mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the
text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure
that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of
your article if no response is received.
Offprints
The corresponding author,
at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can be ordered via the offprint
order form which is sent once the article is accepted for publication. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
For inquiries relating to the submission of articles (including electronic submission
where available) please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle
and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright,
frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating
to proofs, will be provided by the publisher.
|
| |
|
